Ozempic庐 1.34 mg/ml (1 mg/dose) Solution for injection in pre-filled pen

Manufacturer
Novo Nordisk A/S(DENMARK)

Registraction Number
MAL20026058AZ

Content:

• Active Ingredient: Semaglutide 1.34 mg/ml

• Improve blood sugar control in adults with type 2 diabetes mellitus.
• Reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and cardiovascular disease.

• Dosage: The starting dose is 0.25 mg once weekly for the first 4 weeks. After this period, the dose is typically increased to 0.5 mg once weekly. For additional glycemic control, the dose may be increased to 1 mg once weekly. The maximum recommended dosage is 2 mg once weekly.
• Administration: Inject the solution subcutaneously (under the skin) using the pre-filled pen. Follow the instructions provided by your healthcare provider for proper administration.
• Precautions: Inform your doctor if you have any allergies, liver or kidney problems, or if you are pregnant or planning to become pregnant. Regular monitoring of blood sugar levels and other health parameters is necessary during treatment.
• Storage: Store in the refrigerator at 2 to 8°C (36 to 46°F) before use. After initial use, the pen may be stored at room temperature (below 30°C or 86°F) for up to 6 weeks.